APPTECH PAYMENTS CORP (APCX)

US03834B3096 - Common Stock

0.89  +0.01 (+1.14%)

Fundamental Rating

1

Taking everything into account, APCX scores 1 out of 10 in our fundamental rating. APCX was compared to 102 industry peers in the Financial Services industry. Both the profitability and financial health of APCX have multiple concerns. APCX is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year APCX has reported negative net income.
APCX had a negative operating cash flow in the past year.
In the past 5 years APCX always reported negative net income.
In the past 5 years APCX always reported negative operating cash flow.

1.2 Ratios

APCX's Return On Assets of -230.66% is on the low side compared to the rest of the industry. APCX is outperformed by 98.04% of its industry peers.
With a Return On Equity value of -459.39%, APCX is not doing good in the industry: 97.06% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -230.66%
ROE -459.39%
ROIC N/A
ROA(3y)-469.69%
ROA(5y)-837.34%
ROE(3y)-66268%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

APCX's Gross Margin of 64.47% is fine compared to the rest of the industry. APCX outperforms 77.45% of its industry peers.
In the last couple of years the Gross Margin of APCX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for APCX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.99%
GM growth 5Y0.95%

2

2. Health

2.1 Basic Checks

APCX does not have a ROIC to compare to the WACC, probably because it is not profitable.
APCX has more shares outstanding than it did 1 year ago.
APCX has more shares outstanding than it did 5 years ago.
The debt/assets ratio for APCX has been reduced compared to a year ago.

2.2 Solvency

APCX has an Altman-Z score of -29.10. This is a bad value and indicates that APCX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -29.10, APCX is not doing good in the industry: 81.37% of the companies in the same industry are doing better.
APCX has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
APCX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. APCX outperforms 84.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -29.1
ROIC/WACCN/A
WACC13.04%

2.3 Liquidity

A Current Ratio of 0.37 indicates that APCX may have some problems paying its short term obligations.
The Current ratio of APCX (0.37) is worse than 72.55% of its industry peers.
APCX has a Quick Ratio of 0.37. This is a bad value and indicates that APCX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of APCX (0.37) is worse than 71.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37

2

3. Growth

3.1 Past

APCX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.00%.
APCX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.33%.
The Revenue has been growing by 15.05% on average over the past years. This is quite good.
EPS 1Y (TTM)-3%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q44.92%
Revenue 1Y (TTM)11.33%
Revenue growth 3Y15.16%
Revenue growth 5Y15.05%
Revenue growth Q2Q28.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y66.34%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1287.72%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

APCX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year APCX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for APCX!.
Industry RankSector Rank
Dividend Yield N/A

APPTECH PAYMENTS CORP

NASDAQ:APCX (5/8/2024, 12:37:29 PM)

0.89

+0.01 (+1.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.97M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -230.66%
ROE -459.39%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 64.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y66.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.33%
Revenue growth 3Y15.16%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y